DNA Ginkgo Bioworks
- 0.990
- +0.130+15.08%
- 1.000
- +0.010+1.03%
Ginkgo Bioworks News
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it
Ginkgo Bioworks Surges as Much as 31%, Though Pares Gains
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Monday.Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply during Monday's session on reports the company will partner with Ba
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has risen 3.26% since its last report. The company recently reported that it has 270.83 million shares sold short, which is 19.94% of all r
Il Granaio Delle Idee And Ginkgo Bioworks Announce Strategic Collaboration To Optimize Sourdough Strains For Bakery Products
Il Granaio Delle Idee And Ginkgo Bioworks Announce Strategic Collaboration To Optimize Sourdough Strains For Bakery Products
Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks.
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Zoetis (ZTS) and Ginkgo Bioworks Holdings (DNA)
Today's Most Active Stocks: Rallybio, Nikola, Ginkgo Bioworks, and AMD
Modalis Therapeutics Partners With Ginkgo Bioworks, Enhancing Cell And Gene Therapy With CRISPR-GNDM Technology
Modalis Joins Ginkgo's Technology NetworkModalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) announced that it has entered into an agreement with Ginkgo Bioworks (Ginkgo) to join t
Modalis Announces Partnership With Ginkgo Bioworks
Modalis Joins Ginkgo's Technology Network Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) announced that it has entered into an agreement with Ginkgo Bioworks (Ginkgo) to join the Ginkgo
What's Going On With Ginkgo Bioworks Stock?
Ginkgo Bioworks Holdings, Inc. (NASDAQ:DNA) shares are volatile Thursday. The company announced the acquisition of AgBiome's platform assets and the expansion of its strategic partnership with Novo No
Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets
Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets
Ginkgo Bioworks Announced That It Had Been Awarded A Grant From The Bill & Melinda Gates Foundation To Build An Open-access, AI-enabled Measles Forecasting Model To Empower Proactive Public Health Measures
Ginkgo Bioworks Announced That It Had Been Awarded A Grant From The Bill & Melinda Gates Foundation To Build An Open-access, AI-enabled Measles Forecasting Model To Empower Proactive Public Health Mea
Ginkgo Bioworks Announced The Expansion Of Its Strategic Partnership With Novo Nordisk Under A Framework Agreement That Initially Is Contemplated To Run Over Five Years
Ginkgo Bioworks Announced The Expansion Of Its Strategic Partnership With Novo Nordisk Under A Framework Agreement That Initially Is Contemplated To Run Over Five Years
Ginkgo Bioworks Partners With IdeeLab Biotechnology in Brazil
Ginkgo Bioworks (DNA) is partnering with IdeeLab Biotechnology, with the Brazilian company joining the Ginkgo Technology Network to provide agriculture companies in Brazil with product development and manufacturing service, IdeeLab said Monday.
IdeeLab Biotechnology Enters Agreement With Ginkgo Bioworks To Join Ginkgo Technology Network
Ginkgo customers will now have access to IdeeLab's local strain discovery capabilities, as well as the ability to manufacture next-generation products in IdeeLab's manufacturing facilities
Top 10 Worst Performing Cathie Wood ARKK Holdings of 2024
Prozomix And Ginkgo Bioworks Partner On Next-Gen Enzyme Development For Sustainable API Manufacturing
Prozomix And Ginkgo Bioworks Partner On Next-Gen Enzyme Development For Sustainable API Manufacturing
Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs
Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs
CCL, SPB, RARE, and VRSK Are New Additions to GS' Long Duration Basket
Analysis
Price Target
No Data
